1. Home
  2. SCLX vs ANGH Comparison

SCLX vs ANGH Comparison

Compare SCLX & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$5.86

Market Cap

55.1M

Sector

Health Care

ML Signal

N/A

Logo Anghami Inc.

ANGH

Anghami Inc.

N/A

Current Price

$3.44

Market Cap

51.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
ANGH
Founded
2011
2012
Country
United States
United Arab Emirates
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
55.1M
51.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SCLX
ANGH
Price
$5.86
$3.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
59.5K
22.0K
Earning Date
04-10-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,253,000.00
N/A
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$2.25
52 Week High
$34.27
$7.89

Technical Indicators

Market Signals
Indicator
SCLX
ANGH
Relative Strength Index (RSI) 33.68 45.35
Support Level $5.48 $2.99
Resistance Level $7.77 $3.94
Average True Range (ATR) 0.42 0.27
MACD -0.08 -0.00
Stochastic Oscillator 13.24 25.64

Price Performance

Historical Comparison
SCLX
ANGH

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. The Group's three reportable segments: Revenue from subscriptions, Revenue from advertisement, and Revenue from live events. It generates the majority of its revenue from subscriptions segment, which is comes from subscription fees. The advertisement revenue segment generated through the sale of advertising across the Group's content. Revenues from live events are generated from the sale of tickets, food and beverage & sponsorship. It derives maximum revenue from KSA.

Share on Social Networks: